Eurocontrol Technics (EUCTF) 0.1390 $EUCTF Eurocontrol's

New Post Public Reply Private Reply Replies (0) Message Board

Jul 9, 2016 at 6:08 AM

Eurocontrol Technics (EUCTF) 0.1390 $EUCTF

Eurocontrol's XwinSys at SEMICON West 2016
Marketwire Canada - Wed Jun 15, 6:31AM CDT
Patented Hybrid In-Line Metrology System to Be Featured
EUO.VN: 0.190 (unch)

Eurocontrol Reports First Quarter 2016 Results
Marketwired - Mon May 30, 4:46PM CDT
Net Income of $14.9 million
EUO.VN: 0.190 (unch)

Eurocontrol Signs MOU with DigiFlex of Israel
Marketwired - Mon May 16, 7:25AM CDT
Cooperation to Develop New Authentication Applications
EUO.VN: 0.190 (unch)

Eurocontrol's XwinSys Receives United States Patent
Marketwired - Tue May 10, 7:25AM CDT
United States Patent Office Grants Process Patent
EUO.VN: 0.190 (unch)

Eurocontrol Announces SICPA Investment
Marketwired - Thu May 05, 1:21PM CDT
SICPA Increases Eurocontrol Holdings to 10%
EUO.VN: 0.190 (unch)

Acquisition of Shares of Eurocontrol Technics Group Inc.
Marketwire Canada - Wed May 04, 4:59PM CDT
PRILLY, SWITZERLAND--(Marketwired - May 4, 2016) - SICPA Finance SA ("SICPA"

announces its purchase today of 100,000 common shares of Eurocontrol Technics Group Inc. ("Eurocontrol"

, representing 0.11% of the outstanding common shares, through the facilities of the TSX Venture Exchange, bringing SICPA's ownership of common shares of Eurocontrol to 9,276,500, representing 10.09% of the outstanding common shares. The purchases were made at a price of $0.18 per share for investment purposes. SICPA may make additional purchases or sales of Eurocontrol common shares as circumstances warrant.

Eurocontrol's Xenemetrix at Analytica 2016 Munich
Marketwired - Tue May 03, 7:13AM CDT
Eurocontrol Technics Group Inc. (TSX VENTURE: EUO) ("Eurocontrol" or the "Company"

, a Canadian public company specializing in the acquisition, development and commercialization of innovative authentication, verification and certification technologies, is pleased to announce that its subsidiary, Xenemetrix Ltd. ("Xenemetrix"

, will be participating in Analytica 2016, the world's largest conference and exhibition dedicated to solutions along the entire value chain for modern laboratory processes. The Conference and Exhibition is being held May 10th through 13th at MMI - Messe Munich International, Munich, Germany.
EUO.VN: 0.190 (unch)

Eurocontrol Reports Year End 2015 Results
Marketwire Canada - Mon May 02, 8:26AM CDT
Eurocontrol Technics Group Inc. (TSX VENTURE:EUO) ("Eurocontrol" or the "Company"

, a Canadian public company specializing in the acquisition, development and commercialization of innovative security, authentication, verification and certification technologies, announces that it has filed its audited financial statements and Management's Discussion and Analysis ("MD&A"

for the year ended December 31, 2015. Readers are encouraged to refer to the MD&A filed on May 2, 2016 which replaces the MD&A that was filed on April 29, 2016. The May 2, 2016 MD&A amends and restates and supersedes, the Company's MD&A filed on April 29, 2016, which contained numerous typographical errors throughout the document and excluded several other disclosure changes. For this reason, the April 29th MD&A should not be relied upon and readers should refer only to the May 2nd document.
EUO.VN: 0.190 (unch)

IIROC Trade Resumption - Eurocontrol Technics Group Inc.
Newsfile Corp - Mon Mar 28, 10:50AM CDT
Trading resumes in:

Eurocontrol's Xenemetrix Announces MOU With Netafim for Entry Into the Precision Agriculture Industry
Marketwired - Mon Mar 28, 10:44AM CDT
Eurocontrol Technics Group Inc. (TSX VENTURE: EUO) ("Eurocontrol" or the "Company"

, has entered into a Memorandum of Understanding ("MOU"

with Netafim, an Israeli company that is the global leader in drip and micro-irrigation solutions for sustainable agricultural productivity, to develop a unique and innovative testing system utilizing Xenemetrix's Energy Dispersive X-Ray Fluorescence (ED-XRF) technology for farmers and the greater farming community.
EUO.VN: 0.190 (unch)

IIROC Trade Halt - Eurocontrol Technics Group Inc.
Newsfile Corp - Mon Mar 28, 10:28AM CDT
The following issues have been halted by IIROC:

BUYINS.NET: ECH, GRU, SNMX, EUO, FNGN Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Jan 27, 6:37AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of iShares MSCI Chile Investable Market Index Fund (NYSE:ECH), ELEMENTS - MLCX GRAINS (NYSE:GRU), Senomyx Inc (NASDAQ:SNMX), Eurocontrol Technics Group Inc (NYSE:EUO), Financial Engines Inc (NASDAQ:FNGN) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
FNGN: 25.64 (+0.68), ECH: 37.17 (+0.65), EUO: 24.55 (+0.10), SNMX: 2.49 (+0.05), GRU: 4.23 (+0.09)

Eurocontrol's Xenemetrix at Isranalytica 2016
Marketwired - Mon Jan 18, 6:01AM CST
Eurocontrol Technics Group Inc. (TSX VENTURE: EUO) ("Eurocontrol" or the "Company"

, will be participating in Isranalytica 2016, the 19th Annual Meeting of the Israel Analytical Chemistry Society. The Conference and Exhibition is being held on January 19 and 20, 2016, at the David Intercontinental Hotel, in Tel-Aviv, Israel.
EUO.VN: 0.190 (unch)

Eurocontrol Closes Sale of Global Fluids International (GFI) S.A. to SICPA
Marketwired - Tue Jan 05, 11:15AM CST
Eurocontrol Technics Group Inc. (TSX VENTURE: EUO) ("Eurocontrol" or the "Company"

, to SICPA Finance SA ("SICPA"

, a subsidiary of SICPA SA, each a privately owned company based in Switzerland in exchange for cash and post-closing earn-out payments closed effective January 4, 2016. At closing, the Company received $16 million less the $250,000 deposit received by the Company on signing of the Letter of Intent in August 2015, less $395,595 in transaction payments, less $984,128 in settlement of loan amounts owing by Eurocontrol to certain former shareholders of GFI and a working capital adjustment of $47,489. Going forward, Eurocontrol will also receive 5% earn-out payments on all future GFI contracts, inclusive of both marker and logistics, for a period of six years with contracts signed during the fourth through sixth years being paid until the third anniversary of such contracts with a minimum guarantee of $1.5 million per year for six years, being $9 million in the aggregate. The Company will receive the minimum earn-out payments of $1.5 million on a semi-annual basis and additional earn-out payments calculated on 5% of the gross revenue of future GFI contracts, net of the minimum earn-out payments made annually.
EUO.VN: 0.190 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Love Business Group Helps SMEs Navigate Broadband Choices

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

D-Wave Investors Must Decide by Dec 15 Class Suit

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

TORRAS Cases Balance Protection with Slim Design for 2026

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

RYBREVANT's Promising Results in HNSCC Treatment

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...